Single‐access dual‐injection technique ( SADIT ) for high‐risk PCI with Impella CP

2021 ◽  
Author(s):  
Konstantinos Marmagkiolis ◽  
Jaime A. Caballero ◽  
Mehmet Cilingiroglu ◽  
Cezar Iliescu
Keyword(s):  
High Risk ◽  
Injection Technique ◽  
Single Access ◽  
Dual Injection

scholarly journals Community pharmacist-administered seasonal influenza vaccination: a national customer survey

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Dominik Stämpfli ◽  
Adrian Martinez-De la Torre ◽  
Sophie Du Pasquier ◽  
Danielle Stegmann ◽  
Andrea Brügger ◽  
...  
Keyword(s):  
High Risk ◽  
Influenza Vaccination ◽  
Community Pharmacist ◽  
Seasonal Influenza ◽  
Age Groups ◽  
Risk Groups ◽  
Injection Technique ◽  
Equal Distribution ◽  
Seasonal Influenza Vaccination ◽  
Influenza Vaccinations

Abstract Background In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since 2015, Swiss pharmacists are allowed to vaccinate healthy adults after acquiring a certificate of competence for vaccination and blood sampling techniques. We aimed to assess customers of the seasonal influenza vaccination in pharmacies in regard to their satisfaction, motivation, and reasons. Methods Swiss pharmacies collected survey data during a period of 12 weeks from mid-October 2019 to mid-January 2020. Each participating pharmacy was sent 20 questionnaires to be handed out to vaccinated customers. The questionnaire was available in German and French and subdivided into four sections: demographic information, satisfaction, reasons for getting the vaccination, and reasons for choosing a pharmacy as a place of vaccination. We tested for statistical differences in answer tendencies across strata on questionnaire language, age groups, and levels of education. Results Of the 1600 surveys sent, 80 pharmacies sent back 656 completed questionnaires (return rate, 41%). Main age bracket was 65–74 years (26.2%), followed by 55–64 years (24.7%), with an equal distribution of reported sex (female, 49.5%). Of the respondents, 99% would have recommended the service and 88.5% felt very comfortable being vaccinated by a pharmacist. Satisfaction included injection technique, used facilities, preparatory discussions, and pricing of the service. Easy scheduling was a main motivation for choosing a pharmacy as the vaccination provider. We identified minor differences in answer tendencies across questionnaire language and age groups, but not across levels of education. Conclusion Customer satisfaction with community pharmacist-administered seasonal influenza vaccinations is high in Switzerland.

scholarly journals A 17.8–34.8 GHz (64.6%) Locking Range Current-Reuse Injection-Locked Frequency Multiplier with Dual Injection Technique

Electronics ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 1122
Author(s):  
Kwang-Il Oh ◽  
Goo-Han Ko ◽  
Gwang-Sub Kim ◽  
Jeong-Geun Kim ◽  
Donghyun Baek
Keyword(s):  
Power Consumption ◽  
Supply Voltage ◽  
Harmonic Component ◽  
Cmos Technology ◽  
Frequency Multiplier ◽  
Injection Technique ◽  
Frequency Locking ◽  
Current Reuse ◽  
Locking Range ◽  
Dual Injection

A 17.8–34.8 GHz (64.6%) locking range current-reuse injection-locked frequency multiplier (CR-ILFM) with dual injection technique is presented in this paper. A dual injection technique is applied to generate differential signal and increase the power of the second-order harmonic component. The CR core is proposed to reduce the power consumption and compatibility with NMOS and PMOS injectors. The inductor-capacitor (LC) tank of the proposed CR-ILFM is designed with a fourth-order resonator using a transformer with distributed inductor to extend the locking range. The self-oscillated frequency of the proposed CR-ILFM is 23.82 GHz. The output frequency locking range is 17.8–34.8 GHz (64.6%) at a 0-dBm injection power without any additional control including supply voltage, varactor, and capacitor bank. The power consumption of the proposed CR-ILFM is 7.48 mW from a 1-V supply voltage and the die size is 0.75 mm × 0.45 mm. The CR-ILFM is implemented in a 65-nm CMOS technology.

Sign in / Sign up

Export Citation Format

Share Document